Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1652 1654 1658
This examiner grants 60% of resolved cases
Sachi Jauhari is an examiner in Tech Center 1600 and Art Unit 1652, with 5 resolved cases. The allowance rate is 60.0 percent, and the median days to allowance is 1103. These metrics are based on a small sample of 5 resolved cases, which should be considered when evaluating the data. The timeline for these cases is 1103 days. This small volume of 5 resolved cases offers an early glimpse into the examiner's performance.
The interview lift is 80.0 percent, which is a high figure. This 80.0 percent lift suggests that interviews have a substantial impact on the likelihood of allowance compared to the 60.0 percent base rate, though this is influenced by the small volume of 5 resolved cases. For practitioners, the 80.0 percent lift is a signal to pursue interviews. As more than the current 5 resolved cases are completed, these percentages may stabilize, but the initial 80.0 percent lift remains a key strategic consideration.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18287368 | AGENTS FOR MANUFACTURE OF CO-ASSEMBLING PEPTIDES | Non-Final OA | University of Florida Research Foundation, Incorporated |
| 18688469 | New Peptides as Potent and Selective GIP Receptor Agonists | Non-Final OA | Sanofi |
| 18278865 | Antimicrobial Peptides | Non-Final OA | Board of Regents of the University of Nebraska |
| 18697403 | PEPTIDE HAVING ANTI-AGING ACTIVITY, AND USE THEREOF | Non-Final OA | CAREGEN CO., LTD. |
| 18580926 | COMPOUNDS AND COMPOSITIONS FOR TARGETED THERAPY OF RENAL DISEASES | Non-Final OA | SHANGHAI MICURX PHARMACEUTICALS CO., LTD. |
| 18290665 | CONNEXIN 43 FOR USE IN THE TREATMENT OF RETINOBLASTOMA PROTEIN POSITIVE TUMOURS | Non-Final OA | SERVIZO GALEGO DE SAÚDE |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy